SMTL ID : 5f5b.1

Structure of E.Coli GlpG complexed with peptidic inhibitor Ac-VRMA-CHO

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x ACE- VAL- ARG- MET- 5XU: peptidic derivative of Gurken: ACE-VAL-ARG-MET-ALA-aldehyde(Non-covalent)

ACE-VAL-ARG-MET-5XU.1: 17 residues within 4Å: Chain A: M.55, F.81, S.82, H.85, N.89, Q.124, S.128, W.131, F.132, G.133, G.134, L.135, S.136, S.183, M.184, A.185, H.189 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.81, A:A.185 Hydrogen bonds: A:N.89, A:S.128, A:W.131, A:G.133, A:G.133, A:S.136, A:S.183, A:M.184, A:M.184, A:A.185 Water bridges: A:Q.124, A:Q.124

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cho, S. et al., Crystal Structures and Inhibition Kinetics Reveal a Two-Stage Catalytic Mechanism with Drug Design Implications for Rhomboid Proteolysis. Mol.Cell (2016)

Release Date

2016-02-17

Peptides

Rhomboid protease GlpG: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Rhomboid protease GlpG

Related Entries With Identical Sequence